Form 8-K - Current report:
SEC Accession No. 0001206774-20-001703
Filing Date
2020-05-28
Accepted
2020-05-28 16:15:20
Documents
3
Period of Report
2020-05-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3764631-8k.htm 8-K 13860
2 PRESS RELEASE DATED MAY 28, 2020 geron3764631-ex991.htm EX-99.1 46584
3 GRAPHIC geron3764631-8kx5x1.jpg GRAPHIC 4228
  Complete submission text file 0001206774-20-001703.txt   67663
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 20921232
SIC: 2834 Pharmaceutical Preparations